Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Premenstrual Syndrome - Pipeline Review, H2 2017 Featuring Asarina Pharma & Pherin Pharmaceuticals - Research and Markets

Research and Markets
Posted on: 19 Dec 17

The "Premenstrual Syndrome - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Premenstrual Syndrome - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Premenstrual Syndrome (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Premenstrual Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premenstrual Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 2, 2 and 1 respectively.

Premenstrual Syndrome (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Premenstrual Syndrome - Overview
  2. Premenstrual Syndrome - Therapeutics Development
  3. Pipeline Overview
  4. Pipeline by Companies
  5. Products under Development by Companies
  6. Premenstrual Syndrome - Therapeutics Assessment
  7. Assessment by Target
  8. Assessment by Mechanism of Action
  9. Assessment by Route of Administration
  10. Assessment by Molecule Type
  11. Premenstrual Syndrome - Companies Involved in Therapeutics Development
  • Asarina Pharma AB
  • Pherin Pharmaceuticals Inc

For more information about this report visit

View source version on

Business Wire

Last updated on: 19/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.